Growing new endocrine pancreas in situ
Type 1 diabetes mellitus is a major cause of endstage renal disease in young adults. Maintenance of normoglycemia in type 1 diabetics using exogenous insulin is difficult under the best of circumstances. Transplantation therapies are limited by the scarcity of human donor organs, rendering a priorit...
Gespeichert in:
| Veröffentlicht in: | Clinical and experimental nephrology 2006-03, Vol.10 (1), p.1-7 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 7 |
|---|---|
| container_issue | 1 |
| container_start_page | 1 |
| container_title | Clinical and experimental nephrology |
| container_volume | 10 |
| creator | Hammerman, Marc R |
| description | Type 1 diabetes mellitus is a major cause of endstage renal disease in young adults. Maintenance of normoglycemia in type 1 diabetics using exogenous insulin is difficult under the best of circumstances. Transplantation therapies are limited by the scarcity of human donor organs, rendering a priority the identification of an alternative source for replacing insulin-secreting cells. Embryonic pancreatic primordia transplanted into diabetic animal hosts undergo selective endocrine differentiation in situ and normalize glucose tolerance. Pancreatic primordia can be transplanted across isogeneic, allogeneic, and both concordant (rat-to-mouse) and highly disparate (pig-to-rodent) xenogeneic barriers. Successful transplantation of pancreatic primordia depends on obtaining them at defined windows during embryonic development within which the risk of teratogenicity is eliminated, growth potential is maximized, and immunogenicity is reduced. Here we review studies exploring the potential for pancreatic organogenesis post-transplantation of embryonic primordia as a therapy for type 1 diabetes. |
| doi_str_mv | 10.1007/s10157-005-0393-4 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_218131359</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1009553651</sourcerecordid><originalsourceid>FETCH-LOGICAL-c349t-a6f5d503933157f3ef78496384e196c036c0b5e20e0439ed1a71d3f861df9d513</originalsourceid><addsrcrecordid>eNpFkEFLAzEQhYMotlZ_gBdZPHiLznSSzeYopVah4EXPYbtJZIvN1mSX4r83pQsehpnDe28eH2O3CI8IoJ4SAkrFASQH0sTFGZuiIMWV0vo83yTmHJXECbtKaQsAlZb6kk2wlEKgwil7WMXu0IavIrhD4YLtmtgGV-zr0ERXp6INRWr74Zpd-Po7uZtxz9jny_Jj8crX76u3xfOaNyR0z-vSSyuPXSgX8-S8qoQuqRIOddkA5dlINwcHgrSzWCu05KsSrddWIs3Y_Sl3H7ufwaXebLshhvzSzLFCQpI6i_AkamKXUnTe7GO7q-OvQTBHMOYExmQw5ljGiOy5G4OHzc7Zf8dIgv4AMz9bfw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>218131359</pqid></control><display><type>article</type><title>Growing new endocrine pancreas in situ</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Hammerman, Marc R</creator><creatorcontrib>Hammerman, Marc R</creatorcontrib><description>Type 1 diabetes mellitus is a major cause of endstage renal disease in young adults. Maintenance of normoglycemia in type 1 diabetics using exogenous insulin is difficult under the best of circumstances. Transplantation therapies are limited by the scarcity of human donor organs, rendering a priority the identification of an alternative source for replacing insulin-secreting cells. Embryonic pancreatic primordia transplanted into diabetic animal hosts undergo selective endocrine differentiation in situ and normalize glucose tolerance. Pancreatic primordia can be transplanted across isogeneic, allogeneic, and both concordant (rat-to-mouse) and highly disparate (pig-to-rodent) xenogeneic barriers. Successful transplantation of pancreatic primordia depends on obtaining them at defined windows during embryonic development within which the risk of teratogenicity is eliminated, growth potential is maximized, and immunogenicity is reduced. Here we review studies exploring the potential for pancreatic organogenesis post-transplantation of embryonic primordia as a therapy for type 1 diabetes.</description><identifier>ISSN: 1342-1751</identifier><identifier>EISSN: 1437-7799</identifier><identifier>DOI: 10.1007/s10157-005-0393-4</identifier><identifier>PMID: 16544171</identifier><identifier>CODEN: CENPFV</identifier><language>eng</language><publisher>Japan: Springer Nature B.V</publisher><subject>Animals ; Cell Transplantation - methods ; Diabetes Mellitus, Type 1 - physiopathology ; Humans ; Organogenesis ; Pancreas - anatomy & histology ; Pancreas - embryology ; Pancreas - growth & development ; Pancreas, Artificial ; Tissue Engineering - methods</subject><ispartof>Clinical and experimental nephrology, 2006-03, Vol.10 (1), p.1-7</ispartof><rights>Japanese Society of Nephrology 2006</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c349t-a6f5d503933157f3ef78496384e196c036c0b5e20e0439ed1a71d3f861df9d513</citedby><cites>FETCH-LOGICAL-c349t-a6f5d503933157f3ef78496384e196c036c0b5e20e0439ed1a71d3f861df9d513</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16544171$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hammerman, Marc R</creatorcontrib><title>Growing new endocrine pancreas in situ</title><title>Clinical and experimental nephrology</title><addtitle>Clin Exp Nephrol</addtitle><description>Type 1 diabetes mellitus is a major cause of endstage renal disease in young adults. Maintenance of normoglycemia in type 1 diabetics using exogenous insulin is difficult under the best of circumstances. Transplantation therapies are limited by the scarcity of human donor organs, rendering a priority the identification of an alternative source for replacing insulin-secreting cells. Embryonic pancreatic primordia transplanted into diabetic animal hosts undergo selective endocrine differentiation in situ and normalize glucose tolerance. Pancreatic primordia can be transplanted across isogeneic, allogeneic, and both concordant (rat-to-mouse) and highly disparate (pig-to-rodent) xenogeneic barriers. Successful transplantation of pancreatic primordia depends on obtaining them at defined windows during embryonic development within which the risk of teratogenicity is eliminated, growth potential is maximized, and immunogenicity is reduced. Here we review studies exploring the potential for pancreatic organogenesis post-transplantation of embryonic primordia as a therapy for type 1 diabetes.</description><subject>Animals</subject><subject>Cell Transplantation - methods</subject><subject>Diabetes Mellitus, Type 1 - physiopathology</subject><subject>Humans</subject><subject>Organogenesis</subject><subject>Pancreas - anatomy & histology</subject><subject>Pancreas - embryology</subject><subject>Pancreas - growth & development</subject><subject>Pancreas, Artificial</subject><subject>Tissue Engineering - methods</subject><issn>1342-1751</issn><issn>1437-7799</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpFkEFLAzEQhYMotlZ_gBdZPHiLznSSzeYopVah4EXPYbtJZIvN1mSX4r83pQsehpnDe28eH2O3CI8IoJ4SAkrFASQH0sTFGZuiIMWV0vo83yTmHJXECbtKaQsAlZb6kk2wlEKgwil7WMXu0IavIrhD4YLtmtgGV-zr0ERXp6INRWr74Zpd-Po7uZtxz9jny_Jj8crX76u3xfOaNyR0z-vSSyuPXSgX8-S8qoQuqRIOddkA5dlINwcHgrSzWCu05KsSrddWIs3Y_Sl3H7ufwaXebLshhvzSzLFCQpI6i_AkamKXUnTe7GO7q-OvQTBHMOYExmQw5ljGiOy5G4OHzc7Zf8dIgv4AMz9bfw</recordid><startdate>200603</startdate><enddate>200603</enddate><creator>Hammerman, Marc R</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>200603</creationdate><title>Growing new endocrine pancreas in situ</title><author>Hammerman, Marc R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c349t-a6f5d503933157f3ef78496384e196c036c0b5e20e0439ed1a71d3f861df9d513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Animals</topic><topic>Cell Transplantation - methods</topic><topic>Diabetes Mellitus, Type 1 - physiopathology</topic><topic>Humans</topic><topic>Organogenesis</topic><topic>Pancreas - anatomy & histology</topic><topic>Pancreas - embryology</topic><topic>Pancreas - growth & development</topic><topic>Pancreas, Artificial</topic><topic>Tissue Engineering - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hammerman, Marc R</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Clinical and experimental nephrology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hammerman, Marc R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Growing new endocrine pancreas in situ</atitle><jtitle>Clinical and experimental nephrology</jtitle><addtitle>Clin Exp Nephrol</addtitle><date>2006-03</date><risdate>2006</risdate><volume>10</volume><issue>1</issue><spage>1</spage><epage>7</epage><pages>1-7</pages><issn>1342-1751</issn><eissn>1437-7799</eissn><coden>CENPFV</coden><abstract>Type 1 diabetes mellitus is a major cause of endstage renal disease in young adults. Maintenance of normoglycemia in type 1 diabetics using exogenous insulin is difficult under the best of circumstances. Transplantation therapies are limited by the scarcity of human donor organs, rendering a priority the identification of an alternative source for replacing insulin-secreting cells. Embryonic pancreatic primordia transplanted into diabetic animal hosts undergo selective endocrine differentiation in situ and normalize glucose tolerance. Pancreatic primordia can be transplanted across isogeneic, allogeneic, and both concordant (rat-to-mouse) and highly disparate (pig-to-rodent) xenogeneic barriers. Successful transplantation of pancreatic primordia depends on obtaining them at defined windows during embryonic development within which the risk of teratogenicity is eliminated, growth potential is maximized, and immunogenicity is reduced. Here we review studies exploring the potential for pancreatic organogenesis post-transplantation of embryonic primordia as a therapy for type 1 diabetes.</abstract><cop>Japan</cop><pub>Springer Nature B.V</pub><pmid>16544171</pmid><doi>10.1007/s10157-005-0393-4</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1342-1751 |
| ispartof | Clinical and experimental nephrology, 2006-03, Vol.10 (1), p.1-7 |
| issn | 1342-1751 1437-7799 |
| language | eng |
| recordid | cdi_proquest_journals_218131359 |
| source | MEDLINE; SpringerLink Journals |
| subjects | Animals Cell Transplantation - methods Diabetes Mellitus, Type 1 - physiopathology Humans Organogenesis Pancreas - anatomy & histology Pancreas - embryology Pancreas - growth & development Pancreas, Artificial Tissue Engineering - methods |
| title | Growing new endocrine pancreas in situ |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T13%3A22%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Growing%20new%20endocrine%20pancreas%20in%20situ&rft.jtitle=Clinical%20and%20experimental%20nephrology&rft.au=Hammerman,%20Marc%20R&rft.date=2006-03&rft.volume=10&rft.issue=1&rft.spage=1&rft.epage=7&rft.pages=1-7&rft.issn=1342-1751&rft.eissn=1437-7799&rft.coden=CENPFV&rft_id=info:doi/10.1007/s10157-005-0393-4&rft_dat=%3Cproquest_cross%3E1009553651%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=218131359&rft_id=info:pmid/16544171&rfr_iscdi=true |